NJZRKNAKJSUCKN-IYBDPMFKSA-N
C21H22F3N9O — CID 118878131
Data last refreshed: (MolForge compound catalog, from PubChem)
About NJZRKNAKJSUCKN-IYBDPMFKSA-N
NJZRKNAKJSUCKN-IYBDPMFKSA-N (PubChem CID 118878131) has the molecular formula C21H22F3N9O and a molecular weight of 473.46 g/mol. Its IUPAC name is (1S,5R)-3-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-N-[5-(trifluoromethyl)-2-pyridinyl]-3,8-diazabicyclo[3.2.1]octane-8-carboxamide.
Molecular Properties
| Compound Name | NJZRKNAKJSUCKN-IYBDPMFKSA-N |
|---|---|
| PubChem CID | 118878131 |
| Molecular Formula | C21H22F3N9O |
| Molecular Weight | 473.46 g/mol |
| Exact Mass | 473.19 |
| IUPAC Name | (1S,5R)-3-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-N-[5-(trifluoromethyl)-2-pyridinyl]-3,8-diazabicyclo[3.2.1]octane-8-carboxamide |
| SMILES | Cn1cc(Nc2nccc(N3C[C@H]4CC[C@@H](C3)N4C(=O)Nc3ccc(C(F)(F)F)cn3)n2)cn1 |
| InChI | InChI=1S/C21H22F3N9O/c1-31-10-14(9-27-31)28-19-25-7-6-18(30-19)32-11-15-3-4-16(12-32)33(15)20(34)29-17-5-2-13(8-26-17)21(22,23)24/h2,5-10,15-16H,3-4,11-12H2,1H3,(H,25,28,30)(H,26,29,34)/t15-,16+ |
| InChIKey | NJZRKNAKJSUCKN-IYBDPMFKSA-N |
| XLogP | 3.25 |
| TPSA | 104.10 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 473.46 |
| LogP ≤ 5 | 3.25 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118878131 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.